Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Angina IV: Management

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Coronary Circulation

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ischemia-Reperfusion Injury Enhances Lymphatic Endothelial VEGFR3 and Rejection in Cardiac Allografts.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015

Same author

Control of arterial branching morphogenesis in embryogenesis: go with the flow.

Cardiovascular research·2005

Same author

Hemangioblast commitment in the avian allantois: cellular and molecular aspects.

Developmental biology·2002

Same author

Endogenous origin of the lymphatics in the avian chorioallantoic membrane.

Developmental dynamics : an official publication of the American Association of Anatomists·2001

Same author

Development of the avian lymphatic system.

Microscopy research and technique·2001

Same author

A model for gene therapy of human hereditary lymphedema.

Proceedings of the National Academy of Sciences of the United States of America·2001

Search research articles

Related Experiment Video

Updated: Nov 18, 2025

Establishment and Evaluation of a Porcine Vein Graft Disease Model

Establishment and Evaluation of a Porcine Vein Graft Disease Model

Published on: July 25, 2022

Stop the Divide and Build Coronary Arteries.

G Zarkada¹, A Eichmann²

¹Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.

Developmental Cell

|February 9, 2021

Summary

NOTCH signaling is crucial for coronary artery development. This pathway suppresses MYC, a key factor in cell growth and metabolism, offering insights into vascular repair and disease treatment.

More Related Videos

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

Author Spotlight: Enhancing Coronary Artery Revascularization

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

Related Experiment Videos

Last Updated: Nov 18, 2025

Establishment and Evaluation of a Porcine Vein Graft Disease Model

Establishment and Evaluation of a Porcine Vein Graft Disease Model

Published on: July 25, 2022

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

Author Spotlight: Enhancing Coronary Artery Revascularization

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

Area of Science:

Cardiovascular Biology
Developmental Biology
Molecular Biology

Background:

Arterial development is crucial for treating coronary artery disease and arteriovenous malformations.
Understanding the molecular mechanisms governing artery formation is essential for therapeutic strategies.

Purpose of the Study:

To elucidate the role of NOTCH signaling in coronary artery formation.
To investigate the relationship between NOTCH and MYC in vascular development.

Main Methods:

Utilized genetic and molecular biology techniques.
Investigated the interplay between NOTCH and MYC during artery development.

Main Results:

NOTCH signaling was identified as a key driver of coronary artery formation.
NOTCH was shown to suppress MYC, a transcription factor regulating cell cycle and metabolism.
This suppression is critical for proper arterial development.

Conclusions:

NOTCH-mediated suppression of MYC is essential for coronary artery development.
Findings provide a molecular basis for understanding and potentially treating vascular diseases.